More Vitamin D news, as reported on the information website
Vitamin D supplementation increased the likelihood of sustained response to pegylated interferon plus ribavirin therapy for chronic hepatitis C, leading researchers to suggest that vitamin D deficiency may help explain well-known racial/ethnic disparities in treatment response, according to a presentation at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL 2010) last month in Vienna. A recently published related study found that low vitamin D levels were associated with more severe liver fibrosis and poor treatment response.
In recent years, we have been much impressed by the flood of new research on Vitamin D’s health benefits. And it’s particularly interesting that many researchers are now focusing on Vitamin D deficiency as a contributing factor in racial/ethnic disparities in the rates of cardiovascular disease or, as here, in response to treatment for liver disease.
See further information about Vitamin D and cardiovascular health on this Blog, or in the NYBC entries under Vitamin D3 at